Search

file (14) (1)

Investor Overview

Investor Overview

HOMEInvestor Overview

Read More

2024.Dec.11

News

OBI Pharma Earns Sports Enterprise Certification Again
Building a Healthy Workplace and Fulfilling Sustainability Commitments

2024.Dec.02

News

Key Technologies + Innovative Products + Flexible Business Models
Dr. Heidi Wang: Shaping OBI Pharma into a Leading and Thriving Global Biotech Company

2024.Nov.14

News

OBI Pharma Showcases Biomarker Innovations at Singapore APAC Summit
Precision Medicine Tools Drive Success in New Drug Development

Read More

2024.Dec.10

Announcement

Announcement on behalf of OBIGEN to acquire the worldwide intellectual property rights of OBI-858 and sign the technology transfer agreement

2024.Dec.10

Announcement

OBI’s BOD resolved to transfer the worldwide intellectual property rights of OBI-858 and sign the technology transfer agreement

2024.Dec.10

Announcement

The Company’s BOD resolved the redemption and cancellation of the Restricted Stock Awards and the record date of capital reduction

2023 Annual Report

Learn how we created value in 2023 and worked to pursue our purpose of enabling a healthier world.

Download PDF
Read More

Featured
Presentation

2024 BIO Asia Investment Summit

Download PDFAnnual Report

Read More

2024 Annual Shareholders’ Meeting

  • 2024.Jun.17 at 09:00 AM
  • Masterlink Securities Education and Training Center

Governance

Read More

Corporate
Overview​

Board of
Directors​

Special ​
Committee​

Integrity​

Internal
Audit​

Governance
Document​

Investor Relations

Contact